Skip to main content
    Quality & Compliance

    The Role of QA and QP in Temperature Excursion Assessment: What Can Be Automated and What Still Requires Human Decision-Making

    April 19, 2026
    ExcursionAssess Editorial Team

    As pharmaceutical organizations digitalize deviation handling and excursion review, a familiar question appears almost immediately: what parts of temperature excursion assessment can be automated, and what parts still require human quality judgment? The answer matters because the right balance improves consistency and speed, while the wrong balance creates compliance risk and false confidence.

    The regulatory direction is clear. Stability decisions must remain grounded in approved product knowledge, storage conditions, and documented review.[1] GDP requires procedures for handling temperature excursions and for maintaining storage conditions during transport.[2] EU Annex 16 goes further by stating that the Qualified Person is responsible for ensuring that each batch has been manufactured and checked in compliance with GMP and the marketing authorisation before certification.[3] Together, those principles point to a practical conclusion: automation can strengthen the process, but accountable quality judgment cannot be delegated away.

    This article is written for QA leaders, QP-facing teams, digital quality owners, and operational groups that want to design a stronger decision-support model without overstating what software should decide on its own.

    What QA and QP are each trying to achieve

    Quality Assurance is usually the operational guardian of process discipline. In temperature excursion work, QA is often responsible for ensuring that the event is logged correctly, the affected product is controlled, the investigation follows approved procedure, the right evidence is assembled, and the rationale is documented in a way that meets internal and external expectations.

    The Qualified Person, where applicable in the EU framework, operates from a different but connected responsibility. Annex 16 makes clear that the QP is responsible for ensuring that each batch has been manufactured and checked in line with applicable law, the marketing authorisation, and GMP, and that storage and transport conditions should be taken into account before certification.[3] The QP role is therefore not merely clerical approval at the end of a workflow. It is a release-critical quality safeguard.

    Role dimensionQA focusQP focus
    Primary concernProcess control and compliance of the investigationCertification confidence and batch release compliance
    Typical excursion tasksDeviation management, evidence completeness, CAPA, coordinationReview of impact on certification, release suitability, and compliance with MA/GMP
    Interaction with automationCan benefit from workflow standardization and case organizationCan benefit from better evidence visibility, but retains accountable judgment
    Accountability outcomeQuality system robustnessBatch certification and release assurance

    What can be automated effectively

    Many parts of excursion handling are structured enough to benefit from automation or software-assisted workflow. The first area is data intake. Systems can ingest logger files, standardize timestamps, identify out-of-range periods, and organize excursion records in a consistent format. This reduces manual handling errors and gives reviewers cleaner input.

    The second area is workflow control. A system can ensure that required steps are not skipped, that key evidence fields are completed, and that routing follows the organization’s approved escalation logic. This is especially valuable in cross-functional cases where supply chain, warehouse, QA, and technical reviewers all contribute.

    The third area is calculation support. Tools can assist with exposure summaries, event timelines, and supporting metrics such as mean kinetic temperature, as long as those outputs are treated as inputs to review rather than final decisions.[4]

    The fourth area is document organization and traceability. Software can maintain a single case record, preserve attachments, show who reviewed what, and capture a usable audit trail. That matters because weak excursion management often results less from lack of expertise than from fragmented records and inconsistent handoffs.

    The fifth area is consistency scaffolding. Templates, prompts, structured review fields, and evidence checklists help reviewers express decisions more clearly and more consistently. That is a major practical gain, especially in organizations that handle many excursion cases across multiple sites or lanes.

    What should still require human quality judgment

    Automation should not replace expert interpretation of product impact. Human review is still essential whenever the question turns from "what happened" to "what does this mean for quality risk, compliance, and disposition?" That interpretive step depends on product-specific stability knowledge, understanding of critical quality attributes, familiarity with packaging and distribution context, and awareness of uncertainty in the evidence.

    Human judgment is also necessary when evidence conflicts or remains incomplete. A system may detect an excursion, but it cannot by itself resolve whether the logger was representative, whether the route conditions invalidate a simple reading, or whether a prior deviation changes the risk posture of the current case. Those are context-rich decisions.

    Most importantly, release-relevant accountability stays human. Annex 16 states that certification of the finished product batch by a QP signifies that the batch complies with GMP and the requirements of its marketing authorisation and represents the quality release of the batch.[3] That is not a responsibility a software platform can assume.

    A practical boundary between automation and judgment

    The safest design principle is to let automation handle repeatable structure and let people handle accountable interpretation. In practical terms, that means the system should support QA and QP review by improving evidence quality, not by masking uncertainty behind apparent certainty.

    A strong workflow often follows this pattern. The system captures the event, structures the chronology, connects the case to product and shipment context, and prompts the right review fields. QA then confirms completeness, identifies whether the record is adequate for impact review, and decides whether further technical input is needed. Where certification or release confidence is implicated, the QP reviews the relevant facts and rationale in the context of GMP, the marketing authorisation, storage and transport conditions, ongoing stability support, and completed investigations.[3]

    That model gives the organization speed without surrendering accountability. It also aligns well with inspection logic because it shows that the company is using technology to reinforce process discipline rather than to bypass quality oversight.

    How to design a better QA and QP review workflow

    An effective review model begins with clear role definition. Teams should know which tasks are automated, which tasks are preparatory, and which tasks require named human approval. Confusion at that boundary creates either bottlenecks or unsafe delegation.

    The second design principle is evidence visibility. QA and QP reviewers should not have to assemble the case manually from scattered records. The workflow should present the excursion profile, approved storage condition, product context, key stability basis, deviation history, and current recommendation in one governed place.

    The third principle is documented challenge. A good system should make it easy for human reviewers to question assumptions, request clarification, and record why a recommendation was accepted, modified, or rejected. Quality review is stronger when disagreement can be documented constructively rather than hidden in side conversations.

    The fourth principle is audit trail integrity. If the organization uses automated support, it should be able to show what the system generated, what humans reviewed, what changes were made, and who approved the final conclusion. That is not only good governance; it is essential for trust.

    How ExcursionAssess can fit into this model

    ExcursionAssess is best framed as a decision-support layer for quality-managed review. Its value lies in helping organizations centralize data, standardize workflow, improve case visibility, and strengthen documentation quality. Those are precisely the areas where automation can make the largest positive difference.

    Used well, the platform can help QA teams ensure that excursion cases are complete, consistently structured, and easier to escalate. It can also help QP-facing reviewers access a clearer summary of relevant evidence. What it should not imply is that final quality meaning, certification logic, or disposition authority has been transferred from qualified people to software.

    Common mistakes in digital excursion governance

    One frequent mistake is using automation to produce conclusions faster than the supporting evidence justifies. Another is failing to define which decisions remain human-owned, leaving teams unsure whether a recommendation is advisory or final. A third is weak audit-trail design, where the organization cannot later explain how a draft recommendation turned into an approved decision.

    A further mistake is overlooking the release context. Annex 16 notes that ongoing stability data continues to support certification and that investigations pertaining to the batch being certified should be completed to a sufficient level to support certification.[3] Any digital review model that ignores those expectations risks separating excursion handling from the quality release framework it ultimately affects.

    Conclusion

    The most effective temperature excursion workflows do not choose between automation and human review. They assign each to the work it does best. Automation should handle structure, consistency, evidence organization, and calculation support. QA and QP reviewers should retain authority over interpretation, escalation, and certification-relevant judgment. That balance is not only operationally smart; it is the most credible way to align digital workflow design with GDP, stability science, GMP expectations, and real quality accountability.[1] [3]

    If your organization wants to strengthen that balance, ExcursionAssess can help by improving the structure and visibility of the review process while keeping the final quality judgment where it belongs: with qualified human decision-makers.

    Frequently asked questions

    Can temperature excursion review be fully automated?

    Routine parts of the workflow can be automated, but product-impact interpretation and release-relevant decisions still require accountable human review.

    What is the most useful thing automation can do in this process?

    It can improve data quality, structure the workflow, centralize evidence, and make the case easier for QA and QP reviewers to assess consistently.

    Why can’t software make the final decision by itself?

    Because the decision depends on product-specific scientific judgment, uncertainty evaluation, and accountable quality responsibility under GMP and release governance.

    Does QP review matter only at final release?

    No. Storage and transport conditions, ongoing stability support, and completed investigations can all influence certification confidence before release.

    What makes a strong QA/QP digital workflow?

    Clear role boundaries, complete evidence presentation, documented reviewer challenge, and a reliable audit trail showing how the final conclusion was reached.

    References

    1. ICH Harmonised Tripartite Guideline Q1A(R2): Stability Testing of New Drug Substances and Products.
    2. EU Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01).
    3. EU Guidelines on Good Manufacturing Practice, Annex 16: Certification by a Qualified Person and Batch Release.
    4. USP General Chapter <1079.2>: Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products.